GleamWall
中文EN

SSII SS Innovations International, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1676163 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY27.3%
TTM net income YoY15.5%
TTM EPS YoY-16.7%
Revenue 3-yr CAGR104.7%
Net income 3-yr CAGR—

Margins

Gross margin47.7%
Operating margin-27.7%
Net margin-31.5%
FCF margin—
EBITDA margin-24.8%

Returns

ROE-32.3%
ROA-17.4%
ROIC (approx.)-28.4%
Asset turnover0.55x

Leverage & solvency

Liabilities / assets48.3%
Debt / equity0.03x
Current ratio2.10x
Interest coverage-8.95x

Cash quality & payout

Operating cash flow / net income1.00x
Accruals ratio-0.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$6.33M$13.94M$11.10M$14.53M$12.83M$10.00M$5.12M$8.12M
Cost of revenue$3.22M$6.84M$5.77M$8.16M$6.66M$4.09M$4.03M$2.59M
Gross profit$3.11M$7.10M$5.33M$6.38M$6.16M$5.92M$1.09M$3.03M
R&D expense$2.50M$2.40M$995,440$1.39M$786,319$498,600$1.01M$765,412
SG&A expense$4.15M$4.45M$4.50M$3.39M$4.82M$3.43M$3.41M$2.74M
Operating income-$6.06M-$2.27M-$3.64M-$734,997-$1.84M$97,014-$5.92M-$7.63M
Interest expense$454,549$344,761$284,051$335,296$176,636$216,800$379,905$292,954
Pretax income-$5.95M-$2.16M-$3.43M-$705,727-$1.87M$97,038-$5.68M-$1.92M
Income tax-$204,259$505,276$151,352$1.77M$1.85M$353,729——
Net income-$5.75M-$2.66M-$3.58M-$2.47M-$3.72M-$256,691-$5.68M-$7.45M
EBITDA-$5.70M-$1.92M-$3.32M-$425,506-$1.54M$357,375-$5.71M-$7.46M
EPS (basic)-0.03-0.01-0.02—-0.020.00-0.03—
EPS (diluted)-0.03-0.01-0.02—-0.020.00-0.03—
Weighted avg. shares (diluted)209.65M209.42M205.31M—202.86M202.84M188.60M—
Banking
Net interest income$299,701$263,097$261,878$206,796$140,415$71,102$79,236$85,276
Deposits$1.71M—$543,347—————
Balance sheet
Cash & equivalents$8.11M$13.65M$15.98M$3.21M$12.04M$17.61M$22.08M$6.62M
Receivables$16.76M$16.99M$14.05M$12.40M$6.92M$5.97M$3.96M$4.47M
Inventory$22.07M$18.48M$17.07M$17.06M$20.04M$18.26M$14.30M$10.21M
Current assets$70.63M$71.45M$66.26M$48.77M$48.42M$50.79M$47.62M$27.42M
PP&E, net$9.76M$8.64M$8.83M$9.10M$8.25M$8.27M$7.04M$5.39M
Total assets$96.51M$96.98M$90.55M$74.23M$69.58M$69.98M$63.46M$42.39M
Current liabilities$33.70M$31.89M$26.05M$26.24M$21.19M$19.61M$15.00M$21.33M
Short-term debt$52,136——$11.44M————
Long-term debt$1.20M———————
Total debt$1.25M———————
Total liabilities$46.57M$43.58M$36.02M$36.01M$29.93M$27.95M$22.90M$28.93M
Shareholders' equity$49.94M$53.37M$54.52M$38.22M$39.65M$42.02M$40.55M$13.46M
Net debt-$6.86M———————
Shares outstanding200.49M200.17M200.13M194.17M193.59M193.59M193.56M171.58M
Cash flow statement
Operating cash flow-$6.37M-$4.23M-$2.31M-$1.52M-$7.47M-$3.45M-$6.10M-$4.03M
Capital expenditure——$54,189$1.71M$755,075$316,648$872,804-$976,199
Free cash flow——-$2.37M-$3.23M-$8.22M-$3.77M-$6.98M-$3.05M
Investing cash flow-$1.49M-$160,871-$54,189-$1.71M-$755,075-$316,648-$872,804$994,016
Financing cash flow$3.50M$3.48M$18.16M$1.37M$3.09M-$702,098$22.41M$3.41M
Depreciation & amortization$359,249$346,364$323,747$309,491$297,173$260,361$208,882$169,721
Stock-based compensation$2.15M$2.18M$3.14M$2.02M$2.10M$1.63M$2.38M$7.76M

Free plan shows the latest 8 periods; Pro shows all 42 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.